A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis

ORCID
0000-0002-0223-499X
Affiliation
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 19835-35511, Iran;
Ghafouri-Fard, Soudeh;
Affiliation
Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran 19835-35511, Iran;
Azimi, Tahereh;
ORCID
0000-0003-1060-6527
Affiliation
Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Erbil 44001, Iraq;
Hussen, Bashdar Mahmud;
GND
1249707153
ORCID
0000-0001-8381-0591
Affiliation
Institute of Human Genetics, Jena University Hospital, 07747 Jena, Germany
Taheri, Mohammad;
Affiliation
Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran 19835-35511, Iran
Jalili Khoshnoud, Reza

Myasthenia gravis (MG) is an autoimmune condition related to autoantibodies against certain proteins in the postsynaptic membranes in the neuromuscular junction. This disorder has a multifactorial inheritance. The connection between environmental and genetic factors can be established by epigenetic factors, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). XLOC_003810, SNHG16, IFNG-AS1, and MALAT-1 are among the lncRNAs with a possible role in the pathoetiology of MG. Moreover, miR-150-5p, miR-155, miR-146a-5p, miR-20b, miR-21-5p, miR-126, let-7a-5p, and let-7f-5p are among miRNAs whose roles in the pathogenesis of MG has been assessed. In the current review, we summarize the impact of miRNAs and lncRNAs in the development or progression of MG.

Cite

Citation style:
Could not load citation form.

Rights

License Holder: © 2021 by the authors.

Use and reproduction: